Publications by authors named "Longhai Du"

Claim this Profile
A
An injectable multifunctional nanocomposite hydrogel promotes vascularized bone regeneration by regulating macrophages.
Huaiyuan Zhang, Yu Wang, Wenyu Qiao, Xueneng Hu, Huifen Qiang, Longhai Du

J Nanobiotechnology· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing the challenges of infectious bone defects: a review of recent advances in bifunctional biomaterials.
Huaiyuan Zhang, Wenyu Qiao, Yu Liu, Xizhou Yao, Yonghua Zhai, Longhai Du

J Nanobiotechnology· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
ROS-sensitive PD-L1 siRNA cationic selenide nanogels for self-inhibition of autophagy and prevention of immune escape.
Jie Gao, Yonghua Zhai, Weihong Lu, Xianghe Jiang, Jingsheng Zhou, Longhai Du

Bioact Mater· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGFR-targeting peptide conjugated polymer-lipid hybrid nanoparticles for delivery of salinomycin to osteosarcoma.
Longhai Du, Yanlong Xu, Binxu Han, Yu Wang, Qingmin Zeng

J Cancer Res Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Black phosphorus quantum dots camouflaged with platelet-osteosarcoma hybrid membrane and doxorubicin for combined therapy of osteosarcoma.
Yanlong Xu, Longhai Du, Binxu Han, Yu Wang, Jichang Fei

J Nanobiotechnology· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated radiochemotherapy study of ZIF-8 coated with osteosarcoma-platelet hybrid membranes for the delivery of Dbait and Adriamycin.
Longhai Du, Guanghao Zhu, Yanlong Xu, Binxu Han, Yu Wang

Front Bioeng Biotechnol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic effect of growth factor receptor-bound protein 2/epidermal growth factor receptor dual-targeting peptide inhibitor and salinomycin on osteosarcoma.
Zuochong Yu, Yanlong Xu, Longhai Du, Fan Zhang, Minghao Shao

J Cancer Res Ther· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis